2022. Nanoparticle Formulation of a Poorly Soluble Kinase Inhibitor: A Technical Note on Scale-Up. Translational Medicine & Therapeutics Journal. 1, 2 (Oct. 2022), 92–100. DOI:https://doi.org/10.5281/zenodo.22648994.